Status:
COMPLETED
Comparison of Cannabinoids to Placebo in Management of TMJ Pain and Myofascial Pain in the TMJ Region
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
TMJ Disorder
Myofacial Pain
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The aim of this study is to determine whether the cannabinoids taken orally in the form of cannabidiol (CBD oil-a major non-psychoactive component of marijuana) vs placebo (hemp oil) will provide pain...
Detailed Description
The United States National Institute of Health Survey in 2001 conducted a self-reported survey of 30,978 people and determined the overall prevalence of temporomandibular joint and muscles disorders t...
Eligibility Criteria
Inclusion
- Men and women 18-70 years of age
- Ability to give informed consent
- Arthralgia of the temporomandibular joint as defined according to the RDC/TMD criteria (see below chart)\[3\] and/or Myofascial pain of masticatory muscles as defined according to the RDC/TMD criteria (see below chart)\[3\]
- Baseline pain must be greater than 3/10 as self-reported on the VAS
Exclusion
- Allergy to study drug
- Traumatic injury of masticatory muscles or temporomandibular joint within last 12 months
- Mandibular fracture within last 12 months
- Pregnancy or breast feeding
- Initiation of additional treatment of MPD within the past 1 months
- Baseline pain less than 3/10 as self-reported on the VAS
Key Trial Info
Start Date :
August 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 29 2022
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT04298554
Start Date
August 6 2020
End Date
May 29 2022
Last Update
March 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine
New York, New York, United States, 10028